PE99899A1 - Derivados del acido aminoetilfenoxiacetico y agentes para reducir el dolor y promover la eliminacion de calculos en urolitiasis - Google Patents

Derivados del acido aminoetilfenoxiacetico y agentes para reducir el dolor y promover la eliminacion de calculos en urolitiasis

Info

Publication number
PE99899A1
PE99899A1 PE1998000659A PE00065998A PE99899A1 PE 99899 A1 PE99899 A1 PE 99899A1 PE 1998000659 A PE1998000659 A PE 1998000659A PE 00065998 A PE00065998 A PE 00065998A PE 99899 A1 PE99899 A1 PE 99899A1
Authority
PE
Peru
Prior art keywords
urolitiasis
calculations
elimination
derivatives
promote
Prior art date
Application number
PE1998000659A
Other languages
English (en)
Inventor
Tetsuro Tamai
Nobuyuki Tanaka
Hideyuki Muranaka
Harunobu Mukaiyama
Akihito Hirabayashi
Masaaki Sato
Masuo Akahane
Original Assignee
Kissei Pharmaceutical
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Kissei Pharmaceutical filed Critical Kissei Pharmaceutical
Publication of PE99899A1 publication Critical patent/PE99899A1/es

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C217/00Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton
    • C07C217/54Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton having etherified hydroxy groups bound to carbon atoms of at least one six-membered aromatic ring and amino groups bound to acyclic carbon atoms or to carbon atoms of rings other than six-membered aromatic rings of the same carbon skeleton
    • C07C217/56Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton having etherified hydroxy groups bound to carbon atoms of at least one six-membered aromatic ring and amino groups bound to acyclic carbon atoms or to carbon atoms of rings other than six-membered aromatic rings of the same carbon skeleton with amino groups linked to the six-membered aromatic ring, or to the condensed ring system containing that ring, by carbon chains not further substituted by singly-bound oxygen atoms
    • C07C217/60Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton having etherified hydroxy groups bound to carbon atoms of at least one six-membered aromatic ring and amino groups bound to acyclic carbon atoms or to carbon atoms of rings other than six-membered aromatic rings of the same carbon skeleton with amino groups linked to the six-membered aromatic ring, or to the condensed ring system containing that ring, by carbon chains not further substituted by singly-bound oxygen atoms linked by carbon chains having two carbon atoms between the amino groups and the six-membered aromatic ring or the condensed ring system containing that ring
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00Drugs for disorders of the urinary system
    • A61P13/04Drugs for disorders of the urinary system for urolithiasis

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Urology & Nephrology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

SE REFIERE A DERIVADOS DEL ACIDO AMINOETILFENOXIACETICO DE FORMULA (I) O SUS SALES, DONDE R1 ES H, ALQUILO, ARALQUILO; R2 ES H, HALOGENO. SON COMPUESTOS PREFERIDOS ACIDO 2-[4-[2-[[(1S,2R)-2-HIDROXI-2-(4-HIDROXIFENIL)-1-METILETIL]AMINO]ETIL]FENOXI]ACETICO; ACIDO 2-(3-FLUORO-4-[2-[[(1S,2R)-2-HIDROXI-2-(4-HIDROXIFENIL)-1-METILETIL]AMINO]ETIL]FENOXI]ACETICO. TAMBIEN SE REFIERE A UN PROCEDIMIENTO PARA LA PREPARACION. EL COMPUESTO I REDUCE EL DOLOR Y PROMUEVE LA ELIMINACION DE CALCULOS EN LA UROLITIASIS
PE1998000659A 1997-07-25 1998-07-22 Derivados del acido aminoetilfenoxiacetico y agentes para reducir el dolor y promover la eliminacion de calculos en urolitiasis PE99899A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP23323997 1997-07-25

Publications (1)

Publication Number Publication Date
PE99899A1 true PE99899A1 (es) 1999-11-11

Family

ID=16951956

Family Applications (1)

Application Number Title Priority Date Filing Date
PE1998000659A PE99899A1 (es) 1997-07-25 1998-07-22 Derivados del acido aminoetilfenoxiacetico y agentes para reducir el dolor y promover la eliminacion de calculos en urolitiasis

Country Status (29)

Country Link
US (1) US6399660B1 (es)
EP (1) EP1002791B1 (es)
JP (1) JP4002391B2 (es)
KR (1) KR100545473B1 (es)
CN (1) CN1137877C (es)
AR (1) AR013241A1 (es)
AT (1) ATE280146T1 (es)
AU (1) AU754579B2 (es)
BR (1) BR9811483B1 (es)
CA (1) CA2298493C (es)
CO (1) CO4970779A1 (es)
CZ (1) CZ300389B6 (es)
DE (1) DE69827137T2 (es)
ES (1) ES2231996T3 (es)
HK (1) HK1028016A1 (es)
HU (1) HUP0004055A3 (es)
ID (1) ID24062A (es)
IL (1) IL133863A0 (es)
MY (1) MY126743A (es)
NO (1) NO315422B1 (es)
NZ (1) NZ502366A (es)
PE (1) PE99899A1 (es)
PL (1) PL191864B1 (es)
PT (1) PT1002791E (es)
RU (1) RU2196130C2 (es)
SA (1) SA98190661B1 (es)
TW (1) TW418184B (es)
WO (1) WO1999005090A1 (es)
ZA (1) ZA986580B (es)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR100576131B1 (ko) * 1998-04-14 2006-05-03 깃세이 야쿠힌 고교 가부시키가이샤 2­메틸프로피온산유도체 및 그 유도체를 함유하는의약조성물
MY126489A (en) 1998-07-08 2006-10-31 Kissei Pharmaceutical Phenoxyacetic acid derivatives and medicinal compositions containing the same
JP4005771B2 (ja) * 1999-01-21 2007-11-14 キッセイ薬品工業株式会社 アミノエチルフェノキシ酢酸誘導体の結晶多形
CA2479254A1 (en) * 2002-03-22 2003-10-02 Kissei Pharmaceutical Co., Ltd. Preventive or therapeutic agent for renal disease
EP1424079A1 (en) * 2002-11-27 2004-06-02 Boehringer Ingelheim International GmbH Combination of a beta-3-receptor agonist and of a reuptake inhibitor of serotonin and/or norepinephrine
DE10333569A1 (de) * 2003-07-23 2005-02-17 Z & J Technologies Gmbh Einrichtung zur Verteilung von Schüttgut in wenigstens zwei oberhalb der Gicht eines Hochofens angeordnete Bunker
JP4843313B2 (ja) * 2004-02-12 2011-12-21 キッセイ薬品工業株式会社 食道の運動障害を伴う疾患の予防または治療用医薬組成物
JP5156377B2 (ja) * 2005-07-06 2013-03-06 第一ファインケミカル株式会社 光学活性エリスロ−β−アミノアルコールの製法
CN101252952A (zh) * 2005-08-29 2008-08-27 橘生药品工业株式会社 用于由泪液减少所引起的疾病的预防或治疗剂
EP1769792A1 (de) * 2005-09-30 2007-04-04 Boehringer Ingelheim Pharma GmbH & Co.KG Verwendung eines beta-3-Adrenozeptor-Agonisten zur Behandlung von Nieren- und Blasenbeschwerden
ES2302447B1 (es) * 2006-10-20 2009-06-12 Laboratorios Almirall S.A. Derivados de 4-(2-amino-1-hidroxietil)fenol como agonistas del receptor beta2 adrenergico.

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3061334D1 (en) * 1979-06-16 1983-01-20 Beecham Group Plc Ethanamine derivatives, their preparation and use in pharmaceutical compositions
US5776983A (en) * 1993-12-21 1998-07-07 Bristol-Myers Squibb Company Catecholamine surrogates useful as β3 agonists
DK0872246T3 (da) * 1995-11-30 2003-06-10 Kissei Pharmaceutical Medikament til at afhjælpe smerte og fremme fjernelsen af sten ved urolithiasis
AU4320297A (en) * 1996-09-26 1998-04-17 Kissei Pharmaceutical Co. Ltd. 2-amino-1-(4-hydroxy-2-methylphenyl)propanol derivatives

Also Published As

Publication number Publication date
PL338234A1 (en) 2000-10-09
JP4002391B2 (ja) 2007-10-31
ATE280146T1 (de) 2004-11-15
CA2298493A1 (en) 1999-02-04
BR9811483A (pt) 2000-09-19
PT1002791E (pt) 2005-01-31
NO20000371D0 (no) 2000-01-25
TW418184B (en) 2001-01-11
AU8241998A (en) 1999-02-16
WO1999005090A1 (fr) 1999-02-04
AU754579B2 (en) 2002-11-21
US6399660B1 (en) 2002-06-04
CN1137877C (zh) 2004-02-11
CA2298493C (en) 2008-03-18
HUP0004055A3 (en) 2001-10-29
AR013241A1 (es) 2000-12-13
KR100545473B1 (ko) 2006-01-24
EP1002791A4 (en) 2001-09-12
DE69827137T2 (de) 2006-03-09
NO20000371L (no) 2000-01-25
EP1002791B1 (en) 2004-10-20
SA98190661B1 (ar) 2006-09-09
DE69827137D1 (de) 2004-11-25
NZ502366A (en) 2004-12-24
PL191864B1 (pl) 2006-07-31
EP1002791A1 (en) 2000-05-24
KR20010022124A (ko) 2001-03-15
RU2196130C2 (ru) 2003-01-10
ZA986580B (en) 1999-02-04
ES2231996T3 (es) 2005-05-16
BR9811483B1 (pt) 2009-01-13
CZ2000272A3 (cs) 2000-05-17
ID24062A (id) 2000-07-06
HK1028016A1 (en) 2001-02-02
CN1265091A (zh) 2000-08-30
CO4970779A1 (es) 2000-11-07
HUP0004055A2 (hu) 2001-04-28
MY126743A (en) 2006-10-31
IL133863A0 (en) 2001-04-30
NO315422B1 (no) 2003-09-01
CZ300389B6 (cs) 2009-05-06

Similar Documents

Publication Publication Date Title
PE99899A1 (es) Derivados del acido aminoetilfenoxiacetico y agentes para reducir el dolor y promover la eliminacion de calculos en urolitiasis
NL300074I2 (nl) Nieuwe 2-(4-(difenylmethyl)-1-piperazinyl)azijnzuren en hun amiden, werkwijze voor de bereiding daarvan en therapeutische preparaten.
ES555147A0 (es) Un procedimiento para la produccion de un compuesto de tiazolidindiona hipoglicemico
ES8704485A1 (es) Un procedimiento para la preparacion de derivados de piperazina 1,4-disustituidos.
DK282488D0 (da) Farmaceutiske praeparater, deri indgaaende phenylalkylaminger eller salte deraf og forbindelsernes fremstilling
ES520987A0 (es) Procedimiento para la preparacion de derivados de acido espiro (4.(3+n))-2-aza-3carboxilico.
KR870004949A (ko) 치환된 펜에틸아민 유도체의 제조방법
KR890011596A (ko) 불면증 치료용 의약품의 제조에 있어서 1,4-이치환-피페리디닐 화합물의 용도
ES2122360T3 (es) Procedimiento para la obtencion de iminas alifaticas.
ES515222A0 (es) Un procedimiento para preparar 2-(2-hidroxi-3-(1,1-dimetim propilamino)proposi-b-fenilpro-pio fenona.
PE20000181A1 (es) Nuevas sulfonamidas naftil- y anilido- sustituidas
ES542565A0 (es) Un procedimiento para la preparacion de nuevas ocfidrotiazolo (4,5-g) guinolinas.
DE3775229D1 (de) Ungesaettigte aminosaeuren.
KR920016452A (ko) N-(아릴옥시알킬)헤테로아릴-8-아자비시클로[3.2.1]옥탄, 중간체, 이의 제조방법 및 약제로서 이의 용도
PE20020367A1 (es) Derivados de aminociclohexanol como inhibidores de 2,3-oxidoescualeno-lanosterol ciclasa
NO177995C (no) Analogifremgangsmåte for fremstilling av terapeutisk aktive 1,3-dioksanderivater
DK407885A (da) 7-(2-(dialkylamino)ethyl)-4-hydroxy-1,3-benzimidazol-2-oner
RU2000101840A (ru) Производные аминоэтилфеноксиуксусной кислоты и лекарственные средства для успокоения боли и облегчения отхождения камней при мочекаменной болезни
DK74683D0 (da) Diazolyl-alkanoler, fremgangsmade til fremstilling deraf, samt deres anvendelse som antimykotiske midler
GR3003801T3 (es)
SE8505858D0 (sv) Karbazater
CO5160240A1 (es) Polimorfo cristalino del acido 2-[4-[2-[[(1s,2r)-2-hidroxi-2 -(4-hidroxifenil)-1-metiletil]amino]etil]fenoxi]acetico
FI882421A0 (fi) 5-fenyl-1,2,3a,4,5,9b-hexahydro-3h -benz(e)indol, deras framstaellning och anvoendning som laekemedel.
RU95117134A (ru) Производное морфолина или его фармацевтически приемлемая соль и фармацевтическая композиция на его основе
KR890013001A (ko) 자극성 아미노산 수용체 길항제인 테트라졸 유도체

Legal Events

Date Code Title Description
FG Grant, registration
FD Application declared void or lapsed